Controversies in upper GI oncology: first-line systemic treatment in MASLD-associated HCC
ESMO Open
.
2024 Feb;9(2):102245.
doi: 10.1016/j.esmoop.2024.102245.
Epub 2024 Feb 8.
Authors
J Dekervel
1
,
A Casadei-Gardini
2
,
M Pinter
3
Affiliations
1
Digestive Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: jeroen.dekervel@uzleuven.be.
2
Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy.
3
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
PMID:
38335903
PMCID:
PMC10867617
DOI:
10.1016/j.esmoop.2024.102245
No abstract available
MeSH terms
Carcinoma, Hepatocellular* / drug therapy
Humans
Liver Neoplasms* / drug therapy